Qualigen Therapeutics
QLGN
NASDAQ
IPO2020
about QLGN
Qualigen Therapeutics specializes in producing rapid and accurate diagnostic tests for detecting infectious diseases such as COVID-19, H1N1 influenza, and other pathogens.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $4.24 | $6.48 | $4.24 | $7.00M | 12.24M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$1.00 | n/a | n/a | 0% | 0% | 0% |